3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants

BACKGROUND: Urinary bladder cancer is one of the most fatal and expensive diseases of industrialized world. Despite the strenuous efforts, no seminal advances have been achieved for its clinical management. Given the importance of metabolic reprogramming in cancer cell survival and growth, we have h...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Cancer
Egile Nagusiak: Konstantakou, Eumorphia G., Voutsinas, Gerassimos E., Velentzas, Athanassios D., Basogianni, Aggeliki-Stefania, Paronis, Efthimios, Balafas, Evangelos, Kostomitsopoulos, Nikolaos, Syrigos, Konstantinos N., Anastasiadou, Ema, Stravopodis, Dimitrios J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4511243/
https://ncbi.nlm.nih.gov/pubmed/26198749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-015-0399-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak